Evidence map›Paper›PMID 26300668›Full record

ArticleCurrent oncology (Toronto, Ont.)2015

Recent trends in breast, cervical, and colorectal cancer screening test utilization in Canada, using self-reported data from 2008 and 2012.

D Major, D Armstrong, H Bryant, W Cheung, K Decker, G Doyle, V Mai, C M McLachlin, J Niu, J Payne and 1 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

D MajorCanadian Partnership Against Cancer, Toronto, ON; ; Département médecine sociale et préventive, Université Laval, Quebec, QC;
D ArmstrongDivision of Gastroenterology, McMaster University Medical Centre, Hamilton, ON;
H BryantCanadian Partnership Against Cancer, Toronto, ON; ; Departments of Community Health Sciences and Oncology, University of Calgary, Calgary, AB;
W CheungDivision of Medical Oncology, BC Cancer Agency, and Department of Medicine, University of British Columbia, Vancouver, BC;
K DeckerCancerCare Manitoba and University of Manitoba, Winnipeg, MB;
G DoyleBreast Screening Program for Newfoundland and Labrador, St. John's, NL;
V MaiCanadian Partnership Against Cancer, Toronto, ON;
C M McLachlinDepartment of Pathology and Laboratory Medicine, Western University, London, ON;
J NiuCanadian Partnership Against Cancer, Toronto, ON;
J PayneDepartment of Diagnostic Radiology, Dalhousie University, and Nova Scotia Breast Screening Program, Halifax, NS.
N ShuklaCanadian Partnership Against Cancer, Toronto, ON;

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Canada, self-reported data from the Canadian Community Health Survey 2008 and 2012 provide an opportunity to examine overall utilization of breast, cervical, and colorectal cancer screening tests for both programmatic and opportunistic screening. Among women 50-74 years of age, utilization of screening mammography was stable (62.0% in 2008 and 63.0% in 2012). Pap test utilization for women 25-69 years of age remained high and stable across Canada in 2008 and 2012 (78.9% in 2012). The percentage of individuals 50-74 years of age who reporting having at least 1 fecal test within the preceding 2 years increased in 2012 (to 23.0% from 16.9% in 2008), but remains low. Stable rates of screening mammography utilization (about 30%) were reported in 2008 and 2012 among women 40-49 years of age, a group for which population-based screening is not recommended. Although declining over time, cervical cancer screening rates were high for women less than 25 years of age (for whom screening is not recommended). Interestingly, an increased percentage of women 70-74 years of age reported having a Pap test. In 2012, a smaller percentage of women 50-69 years of age reported having no screening test (5.9% vs. 8.5% in 2008), and more women reported having the three types of cancer screening tests (19.0% vs. 13.2%). Efforts to encourage use of screening within the recommended average-risk age groups are needed, and education for stakeholders about the possible harms of screening outside those age groups has to continue.

Indexed as

Cancer screeningtrends

Identifiers

PMID26300668
PMCPMC4530815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.